KEY POINTS
Amgen is among a crowded field of drugmakers racing to develop the next blockbuster weight loss drug — but it’s taking an entirely different approach than its rivals.
The biotech company is testing a monthly injection that works differently from Wegovy and Zepbound and appears to help patients maintain their weight loss even after they stop taking it.
Still, more data is needed to see how competitive Amgen will be in the obesity market.

Posted in

Iron Will

Leave a Comment

You must be logged in to post a comment.